chronic fatigue syndrome: a medical condition characterized by long-term fatigue and other symptoms that limit a person's ability to carry out ordinary daily activities.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
326 |
4. Check minimum number of eventsNone |
326 |
5. Include endpointsNone |
326 |
6. Filter based on genotype QC (FinnGen only) |
314 |
Control definitions (FinnGen only)
- Control exclude
- G6_OTHNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G93
- Name in latin
- Syndroma lassitudinis postvirale
Similar endpoints
↥List of similar endpoints to
Postviral fatigue syndrome
based on the number of shared cases.
Similar with more cases:
- Cerebral cysts
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1622 | 1089 | 525 |
| Only index persons | 1588 | 1074 | 514 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.01 |
| Only index persons | 0.03 | 0.04 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 34.76 | 35.80 | 32.61 |
| Only index persons | 34.81 | 35.74 | 32.86 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 314 | 254 | 60 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.03 |
| Median age at first event (years) | 39.55 | 39.90 | 38.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 326
- Matched controls
- 3260
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G93.3
ICD-10 Finland
Postviral fatigue syndrome
+∞
307.7
326
7
R53
ICD-10 Finland
Malaise and fatigue
12.9
119.8
228
498
R68.88
ICD-10 Finland
Other specified general symptoms and signs, not elsewhere classified.
39.0
70.1
44
13
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
9.6
62.5
85
115
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
11.3
55.5
64
69
N06AX21
ATC
duloxetine; oral
6.7
54.1
111
234
N04BC05
ATC
pramipexole; oral
10.0
48.8
61
73
N06AX16
ATC
venlafaxine; oral
5.7
48.5
126
327
M79.7
ICD-10 Finland
Fibromyalgia
10.5
48.2
58
66
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.0
48.2
112
263
A04
ICPC
Weakness/tiredness general
5.6
45.0
114
287
TAB00
NOMESCO Finland
Lumbar puncture
9.9
44.7
56
67
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
9.7
44.2
56
68
N06AX12
ATC
bupropion; oral
6.2
43.8
91
191
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
8.2
42.8
63
92
Z01.8
ICD-10 Finland
Other specified special examinations
4.8
40.9
133
408
F48.0
ICD-10 Finland
Neurasthenia
214.3
37.6
38
*
XA800
NOMESCO Finland
Neuropsychological investigation
8.6
36.7
51
69
L28
ICPC
Limited function/disability (L)
6.0
36.5
76
158
M35.7
ICD-10 Finland
Hypermobility syndrome
13.4
36.5
36
30
N03AX12
ATC
[U] gabapentin; oral
5.0
35.0
94
244
G47.3
ICD-10 Finland
Sleep apnoea
4.4
31.6
104
315
N03AX16
ATC
[U] pregabalin
4.1
29.9
109
354
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
8.2
29.5
42
58
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
6.2
29.4
56
106
R50.9
ICD-10 Finland
Fever, unspecified
4.3
28.5
94
283
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
8.4
28.2
39
52
R51.80
ICD-10 Finland
Headache
3.8
27.8
117
417
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
8.2
27.8
39
53
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
5.2
27.6
64
145
R42
ICD-10 Finland
Dizziness and giddiness
4.2
27.4
92
280
C07AB07
ATC
bisoprolol; oral
3.5
26.4
140
577
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
5.6
25.9
55
115
A28
ICPC
Limited function/disability NOS
5.9
25.0
49
95
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.8
24.1
61
148
N04BC09
ATC
rotigotine; transdermal
93.9
24.0
26
*
R4110
NOMESCO Finland
Physiotherapy
3.5
23.8
117
455
C07AA05
ATC
propranolol; systemic
3.4
23.6
126
516
U09.9
ICD-10 Finland
Post COVID-19 condition, unspecified
22.2
23.6
34
17
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
7.3
22.6
35
53
R03DC03
ATC
montelukast; oral
3.5
22.6
101
369
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
56.2
22.4
26
5
M79.0
ICD-10 Finland
Rheumatism, unspecified
8.1
22.0
31
42
N06AX26
ATC
vortioxetine; oral
4.4
21.7
63
170
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
21.5
138
624
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.3
21.2
108
426
XF404
NOMESCO Finland
Ambulatory ECG
6.4
21.1
37
64
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
223.7
20.8
21
*
N06AX22
ATC
agomelatine; oral
7.5
20.7
31
45
N06AX11
ATC
mirtazapine; oral
3.0
20.7
154
753
H02AB06
ATC
prednisolone; systemic
2.9
20.2
179
957
G90.8
ICD-10 Finland
Other disorders of autonomic nervous system
+∞
20.0
19
*
N06AB04
ATC
citalopram; systemic
3.2
19.5
100
393
A02BA02
ATC
ranitidine; systemic
3.7
19.4
72
231
R06.0
ICD-10 Finland
Dyspnoea
3.2
19.3
105
427
ZY010
NOMESCO Finland
Hospital outpatient
4.6
19.3
50
123
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.5
19.1
39
78
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.8
19.0
47
111
A02BC05
ATC
esomeprazole; systemic
2.8
18.8
155
790
G43.9
ICD-10 Finland
Migraine, unspecified
3.9
18.8
64
193
Z2445
NOMESCO Finland
Psychologist
5.1
18.6
42
92
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
8.4
18.5
25
32
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.8
18.5
142
696
N05BA04
ATC
oxazepam; oral
2.9
18.5
120
538
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.3
18.2
52
138
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.9
18.1
43
98
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.2
17.9
86
324
G43.3
ICD-10 Finland
Complicated migraine
6.8
17.9
29
46
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.4
17.8
37
75
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
7.9
17.6
25
34
H03AA01
ATC
levothyroxine sodium; systemic
3.0
17.6
109
474
N05AH04
ATC
quetiapine; oral
3.0
17.5
106
455
N06BA07
ATC
modafinil; oral
53.0
17.2
20
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.0
17.1
55
159
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
17.0
61
190
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.7
16.9
33
63
N06CA01
ATC
amitriptyline and psycholeptics; systemic
4.3
16.8
48
127
R03AC02
ATC
salbutamol; inhalant
2.8
16.5
230
1495
C01CA24
ATC
epinephrine; parenteral
4.0
16.5
52
148
R00.0
ICD-10 Finland
Tachycardia, unspecified
5.5
16.4
33
65
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.4
16.3
34
69
N17
ICPC
Vertigo/dizziness
3.8
16.2
55
165
Z2446
NOMESCO Finland
Social worker
4.4
16.2
44
112
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.3
16.2
71
252
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.1
15.9
48
132
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.5
15.9
41
100
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.4
15.4
63
213
UJF30
NOMESCO Finland
Ileoscopy through colon
4.0
15.4
48
135
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
4.1
15.2
46
127
B03BA03
ATC
hydroxocobalamin; parenteral
6.9
15.1
24
37
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.6
15.1
57
183
R00.2
ICD-10 Finland
Palpitations
3.8
15.1
51
152
N06AB03
ATC
fluoxetine; oral
3.4
15.0
63
217
M79.1
ICD-10 Finland
Myalgia
3.0
15.0
84
343
SPAT1215
SPAT
Assessment of need for medical rehabilitation
6.5
14.9
25
41
SPAT1229
SPAT
Assessment of need for aid
7.0
14.7
23
35
N06BA04
ATC
methylphenidate; oral
4.0
14.4
45
127
XF402
NOMESCO Finland
ECG with work load test
5.2
14.3
31
65
G44.2
ICD-10 Finland
Tension-type headache
2.9
14.3
82
338
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
7.1
14.2
22
33
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
3.3
14.2
60
207
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.2
14.2
41
109
N03AX11
ATC
topiramate; oral
5.6
14.2
28
54
A01
ICPC
Pain general/multiple sites
3.9
14.1
45
129
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
12.2
14.0
25
22
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.8
14.0
47
139
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
5.7
14.0
27
51
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.1
13.9
67
250
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
13.8
162
942
F32.1
ICD-10 Finland
Moderate depressive episode
3.4
13.8
55
183
H02AB09
ATC
hydrocortisone; systemic
10.8
13.7
26
26
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.3
13.7
38
98
N04BD01
ATC
selegiline; oral
27.1
13.5
18
7
A02BC02
ATC
pantoprazole; systemic
2.5
13.4
220
1479
N06AG02
ATC
moclobemide; oral
5.9
13.1
24
43
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.6
12.9
99
472
R52.9
ICD-10 Finland
Pain, unspecified
3.4
12.8
50
164
N06AA09
ATC
amitriptyline; systemic
4.0
12.7
39
108
N06AB10
ATC
escitalopram; oral
2.5
12.7
116
599
XKD00
NOMESCO Finland
Uroflowmetry
5.2
12.6
27
56
J01MA02
ATC
ciprofloxacin; systemic
2.4
12.5
121
640
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.8
12.4
29
65
R4120
NOMESCO Finland
Occupational therapy
4.1
12.4
36
96
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
12.4
88
403
M25.5
ICD-10 Finland
Pain in joint
2.3
12.3
138
777
K30
ICD-10 Finland
Functional dyspepsia
3.1
12.2
57
208
R52.2
ICD-10 Finland
Other chronic pain
5.3
12.1
25
50
IGY99
NOMESCO Finland
Other psychiatric treatment contact
5.1
12.1
26
54
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.3
12.1
33
84
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.3
12.0
50
170
J01AA02
ATC
doxycycline; systemic
2.6
12.0
254
1870
M03BX01
ATC
baclofen; systemic
11.1
12.0
22
21
R13
ICD-10 Finland
Dysphagia
4.9
11.9
27
59
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
11.8
81
363
J45.9
ICD-10 Finland
Asthma, unspecified
2.7
11.8
75
324
N03AE01
ATC
clonazepam; systemic
4.6
11.7
29
68
N28
ICPC
Limited function/disability (N)
23.9
11.7
16
7
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.2
11.4
32
83
R5140
NOMESCO Finland
Monitoring the use of the aid
3.6
11.4
40
122
Z3226
NOMESCO Finland
Physiotherapist
2.7
11.4
70
297
N05AB03
ATC
perphenazine; systemic, rectal
5.8
11.3
21
38
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.0
11.3
57
217
R11
ICD-10 Finland
Nausea and vomiting
3.3
11.3
47
160
N02AX02
ATC
tramadol; systemic, rectal
2.3
11.2
134
770
G43.8
ICD-10 Finland
Other migraine
6.0
11.1
20
35
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
5.1
11.1
24
50
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.3
11.1
46
156
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.6
11.0
74
328
G44.8
ICD-10 Finland
Other specified headache syndromes
11.1
10.9
20
19
F34.1
ICD-10 Finland
Dysthymia
4.1
10.8
31
82
OAB93, ,
SPAT
3.2
10.7
47
165
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
5.3
10.7
22
44
XQ800
NOMESCO Finland
Prick test
3.3
10.6
44
149
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.5
10.5
80
375
R03BA08
ATC
ciclesonide; inhalant
3.2
10.5
44
150
J31.0
ICD-10 Finland
Chronic rhinitis
3.0
10.5
51
190
H04.10
ICD-10 Finland
Dry eye syndrome
2.9
10.5
54
208
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.3
10.5
28
70
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.0
10.4
51
191
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.2
10.3
43
146
N05CF02
ATC
zolpidem; oral
2.6
10.3
72
324
N07AA02
ATC
pyridostigmine; systemic
24.3
10.3
14
6
AA1AD
NOMESCO Finland
CT of head and brain
2.7
10.3
64
272
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
10.2
70
312
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
11.8
10.2
18
16
F41.09
ICD-10 Finland
UNS Panic Syndrome
4.3
10.2
27
67
Z71.8
ICD-10 Finland
Other specified counselling
2.2
10.2
138
827
M54.2
ICD-10 Finland
Cervicalgia
3.0
10.1
48
176
J01FA09
ATC
clarithromycin; systemic
2.2
10.1
130
762
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
15.2
10.1
16
11
N06AB06
ATC
sertraline; oral
2.6
10.1
67
294
N02CC03
ATC
zolmitriptan; nasal, oral
3.2
10.0
42
143
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.5
10.0
75
349
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
5.4
10.0
20
39
UJF32
NOMESCO Finland
Coloscopy
2.5
9.9
71
323
N02BF02
ATC
pregabalin; oral
3.8
9.9
31
87
R20.2
ICD-10 Finland
Paraesthesia of skin
3.2
9.9
41
139
N05CF01
ATC
zopiclone; oral
2.3
9.9
99
524
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.8
9.8
31
88
H02AA02
ATC
fludrocortisone; oral
56.7
9.7
11
*
G47.9
ICD-10 Finland
Sleep disorder, unspecified
5.0
9.7
21
44
Z3231
NOMESCO Finland
Registered nurse
2.3
9.6
99
529
R07.0
ICD-10 Finland
Pain in throat
3.0
9.5
44
159
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.7
9.5
58
244
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
10.0
9.4
18
19
F51.0
ICD-10 Finland
Nonorganic insomnia
2.3
9.4
89
459
C09CA06
ATC
candesartan; oral
2.4
9.4
76
366
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.4
9.3
24
58
Z01.9
ICD-10 Finland
Special examination, unspecified
3.7
9.3
30
86
K07.60
ICD-10 Finland
Snapping jaw
3.1
9.3
41
144
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.4
9.2
74
354
G54.0
ICD-10 Finland
Brachial plexus disorders
4.6
9.2
22
50
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
5.2
9.2
19
38
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
9.1
79
392
Z02.7
ICD-10 Finland
Issue of medical certificate
3.2
9.1
37
124
R06.5
ICD-10 Finland
Mouth breathing
3.1
8.9
39
136
R96
ICPC
Asthma
3.2
8.9
37
125
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.9
8.9
27
74
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
8.9
87
453
T78.4
ICD-10 Finland
Allergy, unspecified
3.7
8.9
29
84
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
4.5
8.8
22
52
A06AC01
ATC
ispaghula (psylla seeds); oral
2.3
8.7
79
399
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
12.0
8.7
15
13
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
8.6
71
343
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
28.4
8.5
11
*
WX723
NOMESCO Finland
CPAP therapy
4.7
8.5
20
45
R05
ICD-10 Finland
Cough
2.3
8.5
79
403
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.7
8.4
27
77
N05BA01
ATC
diazepam; systemic, rectal
2.8
8.4
45
176
J45.1
ICD-10 Finland
Nonallergic asthma
3.6
8.4
29
87
M54.5
ICD-10 Finland
Low back pain
2.0
8.4
138
873
R03BA05
ATC
fluticasone; inhalant
2.3
8.4
78
397
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
9.8
8.4
16
17
M03BC01
ATC
orphenadrine (citrate); systemic
2.1
8.4
100
563
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.6
8.3
55
240
R03AK11
ATC
formoterol and fluticasone; inhalant
7.9
8.3
18
24
R02
ICPC
Shortness of breath/dyspnoea
2.8
8.2
45
178
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.1
8.2
109
637
N06AB05
ATC
paroxetine; oral
3.3
8.2
32
104
G50.1
ICD-10 Finland
Atypical facial pain
9.3
8.1
16
18
R4110, ,
SPAT
3.2
8.1
34
116
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
22.7
8.1
11
5
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
8.0
82
433
N06AX03
ATC
mianserin; oral
4.1
8.0
22
56
WZC00
NOMESCO Finland
Treatment plan or consultation
2.0
8.0
128
799
N06AX05
ATC
trazodone; oral
6.9
8.0
19
29
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.8
8.0
18
39
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
7.9
150
991
R4190
NOMESCO Finland
Nutritional therapy
3.8
7.9
24
66
R51.81
ICD-10 Finland
Facial pain NOS
7.3
7.9
18
26
R06AE07
ATC
cetirizine; oral
1.9
7.9
171
1183
A02BA03
ATC
famotidine; systemic
11.2
7.9
14
13
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.6
7.8
26
76
R06AX13
ATC
loratadine; oral
2.2
7.8
73
371
K59.09
ICD-10 Finland
Constipation, unspecified
4.1
7.8
22
57
SPAT1216
SPAT
Assessment of functional ability
3.0
7.8
35
124
G44.0
ICD-10 Finland
Cluster headache syndrome
7.7
7.8
17
23
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
7.7
7.8
17
23
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
7.8
120
739
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.2
7.7
21
53
J45
ICD-10 Finland
Asthma
2.7
7.7
45
184
U08.9
ICD-10 Finland
Personal history of COVID-19, unspecified
12.2
7.6
13
11
M01AC06
ATC
meloxicam; systemic, rectal
2.0
7.6
104
612
R01AD12
ATC
fluticasone furoate; nasal
1.9
7.6
143
940
R01AD05
ATC
budesonide; nasal
3.0
7.6
35
126
E0000UV, ,
ATC
1.9
7.6
151
1011
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.8
7.5
39
150
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
6.7
7.5
18
28
J01FA06
ATC
roxithromycin; oral
1.9
7.5
132
849
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.4
7.4
58
273
F60.5
ICD-10 Finland
Anankastic personality disorder
9.7
7.4
14
15
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
7.3
7
*
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
16.2
7.3
11
7
R51
ICD-10 Finland
Headache
2.9
7.3
36
135
J02AC01
ATC
fluconazole; systemic
1.9
7.2
165
1150
NXL00
NOMESCO Finland
Biopsy of muscle
30.8
7.2
9
*
L19
ICPC
Muscle symptom/complaint NOS
5.9
7.2
19
34
N03AX09
ATC
lamotrigine; oral
3.0
7.2
32
113
N99
ICPC
Neurological disease other
20.6
7.2
10
5
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.8
7.2
22
61
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.6
7.1
24
71
N94.1
ICD-10 Finland
Dyspareunia
7.3
7.1
16
23
R06AX26
ATC
fexofenadine; oral
2.7
7.1
40
161
D01
ICPC
Abdominal pain/cramps general
2.3
7.0
59
286
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.4
7.0
26
82
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
2.6
7.0
44
187
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.2
7.0
28
93
N02CC05
ATC
almotriptan; oral
3.1
6.9
30
104
A99
ICPC
Disease/condition unspecnature/site
3.1
6.9
30
104
N05AX12
ATC
aripiprazole; systemic
3.0
6.9
31
110
3007
Kela drug reimbursment
Erenumab and fremanezumab
5.9
6.9
18
32
M79.6
ICD-10 Finland
Pain in limb
1.9
6.7
141
950
H53.1
ICD-10 Finland
Subjective visual disturbances
3.0
6.7
30
106
R68.81
ICD-10 Finland
A constant or recurrent sensitivity to experience symptoms and signs in relation to common factors in the environment, not elsewhere classified.
23.1
6.7
9
*
J05AB11
ATC
valaciclovir; oral
2.3
6.7
57
278
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.6
6.7
22
64
N29
ICPC
Neurological sympt/complt other
8.1
6.7
14
18
P29
ICPC
Psychological sympt/compl other
2.4
6.7
47
211
A03
ICPC
Fever
2.0
6.7
84
478
A07AA02
ATC
nystatin; oral
4.3
6.6
17
41
M01AE02
ATC
naproxen; oral, rectal
1.9
6.6
208
1585
U09
ICD-10 Finland
Post COVID-19 condition
9.0
6.6
13
15
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
9.0
6.6
13
15
SPAT1301
SPAT
No procedures
1.9
6.6
98
590
P01AB01
ATC
metronidazole; oral, rectal
1.8
6.6
142
964
A02BC04
ATC
rabeprazole; oral
2.6
6.5
39
162
ZX120
NOMESCO Finland
Intravenous
2.8
6.5
32
120
T86
ICPC
Hypothyroidism/myxoedema
3.9
6.5
19
51
ZYC01
NOMESCO Finland
Remote contact by phone
3.0
6.4
29
103
N05BE01
ATC
buspirone; oral
5.4
6.4
18
35
E61.1
ICD-10 Finland
Iron deficiency
3.4
6.4
23
71
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
6.4
44
195
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
6.4
44
195
UJF92
NOMESCO Finland
Capsular endoscopy
6.2
6.4
16
27
J01FF01
ATC
clindamycin; systemic
2.0
6.4
87
508
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.1
6.4
65
341
SPAT1240
SPAT
Therapeutic discussion
2.2
6.4
60
305
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.7
6.4
36
145
A02BC01
ATC
omeprazole; systemic
2.0
6.3
81
463
R06.4
ICD-10 Finland
Hyperventilation
7.3
6.3
14
20
R06AX22
ATC
ebastine; oral
2.0
6.3
76
425
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
6.3
228
1804
N80.9
ICD-10 Finland
Endometriosis, unspecified
3.7
6.3
20
57
R01AD08
ATC
fluticasone; nasal
1.9
6.3
112
715
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
27.2
6.3
8
*
K59.1
ICD-10 Finland
Functional diarrhoea
3.6
6.3
21
62
A02BC03
ATC
lansoprazole; oral
2.0
6.2
80
457
Z2221
NOMESCO Finland
Medical doctor
1.9
6.2
106
666
M01AH01
ATC
celecoxib; oral
2.4
6.2
46
211
LCA06
NOMESCO Finland
Biopsy of endometrium
2.2
6.2
56
280
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
7.9
6.2
13
17
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.2
6.2
24
78
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
3.3
6.1
23
73
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
8.8
6.1
12
14
G47.8
ICD-10 Finland
Other sleep disorders
5.4
6.1
17
33
R01AD09
ATC
mometasone; nasal
1.8
6.1
177
1305
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
179
238
15.46
142.44
2.5
1.9
379.04
372.92
nmol/l
0.16
169
225
157
201
14.14
126.75
2.9
2.1
19.89
18.64
au/ml
—
8
16
75
66
14.46
75.16
1.3
1.3
263.62
164.70
u/ml
2.54
53
42
75
68
14.03
73.74
1.3
1.3
—
—
—
0
0
215
741
6.58
62.33
2.1
1.7
98.55
95.86
pmol/l
0.33
117
419
61
57
12.93
58.35
1.3
1.5
85.25
108.36
u/ml
1.40
29
14
102
185
7.57
57.90
2.9
2.4
10.09
10.31
g/l
0.28
93
175
227
925
5.79
51.11
5.4
6.1
1.22
1.22
mmol/l
0.12
195
796
119
284
6.02
50.50
2.9
2.1
16.51
14.60
umol/l
2.22
111
265
107
232
6.38
50.31
2.7
2.2
29.04
25.06
%
2.19
97
196
69
94
9.04
49.94
1.8
1.3
—
—
—
0
0
111
256
6.06
48.72
2.8
2.1
2.48
2.48
g/l
0.03
106
234
206
814
5.16
47.04
4.8
6.0
1.22
1.22
mmol/l
0.14
198
759
234
1035
5.47
45.98
3.0
2.3
76.16
72.46
nmol/l
1.28
224
975
129
377
5.01
42.39
1.7
1.5
446.77
44058385.12
pmol/l
0.80
121
345
269
1443
5.94
38.63
5.1
2.8
79.23
66.76
ug/l
0.98
263
1366
193
814
4.36
38.19
3.4
4.6
38.04
37.40
g/l
1.09
181
769
46
52
10.14
38.12
1.3
1.6
14.70
81.84
e6/l
0.83
37
44
46
52
10.14
38.12
1.2
1.6
1.03
2.19
e6/l
1.35
35
42
104
280
4.99
37.26
1.6
1.3
83.84
159.74
iu/ml
1.71
40
121
104
281
4.97
37.08
3.0
3.6
0.84
0.83
mmol/l
0.25
94
269
58
91
7.54
36.75
1.7
1.1
—
—
—
0
0
33
26
14.01
34.54
1.1
1.2
—
—
—
0
0
169
692
3.99
33.88
2.1
2.8
2.33
2.35
mmol/l
1.40
156
637
173
729
3.93
33.06
3.1
2.7
—
—
—
0
0
301
1895
8.67
32.58
6.2
3.5
6.13
8.42
mm/h
8.67
295
1781
124
426
4.08
31.66
1.6
1.3
22.39
21.56
nmol/l
0.20
118
387
35
36
10.77
30.86
1.5
1.9
5.07
5.14
kpa
0.19
35
36
31
27
12.58
30.47
1.1
1.1
—
—
—
0
0
259
1487
4.61
30.36
8.1
8.8
3.74
3.92
e9/l
0.78
239
1315
288
1810
6.07
29.42
7.3
6.2
70.37
73.23
u/l
0.55
281
1710
227
1219
3.84
28.66
4.1
4.6
5.83
6.29
mmol/l
5.00
210
1077
78
214
4.48
26.57
1.5
1.2
135.50
131.38
u/ml
0.03
72
192
87
266
4.10
25.57
1.8
1.5
1140.27
1109.21
nmol/l
0.11
70
213
48
94
5.82
24.17
1.8
8.0
24.94
25.18
mmol/l
0.23
48
94
47
95
5.61
22.84
1.7
2.4
—
—
—
0
0
130
552
3.25
22.78
2.9
2.2
2.19
2.77
mg/l
4.35
114
478
317
2515
10.43
22.69
7.9
4.7
1.60
2.17
mu/l
0.67
310
2401
131
567
3.19
22.11
3.0
2.5
0.07
0.31
e6/l
3.94
106
430
149
695
3.11
22.07
2.2
1.4
1.86
2.09
g/l
1.93
109
458
304
2175
6.89
22.06
6.7
4.1
14.42
14.27
pmol/l
0.54
298
2046
213
1255
3.01
20.01
3.9
2.9
0.00
0.00
estimate
-0.00
59
276
214
1270
2.99
19.73
3.9
2.9
0.00
0.00
estimate
-0.00
62
260
212
1257
2.96
19.48
5.0
4.0
0.00
0.00
estimate
0.50
61
264
87
318
3.37
19.12
2.0
2.2
2.40
2.41
mmol/l
0.54
71
276
50
124
4.58
19.07
2.6
1.8
—
—
—
0
0
83
307
3.29
17.78
2.4
2.4
3.48
3.56
e6/l
0.03
49
164
193
1125
2.75
17.70
4.5
5.4
9.24
10.14
umol/l
1.06
181
1071
166
903
2.71
17.39
3.2
3.1
24.58
28.31
u/l
1.57
160
868
102
432
2.98
17.25
2.6
2.2
4.45
10.00
e6/l
2.08
92
387
25
14
19.21
16.75
1.8
3.5
351.72
397.79
u/ml
0.30
25
14
133
660
2.71
16.56
3.2
2.6
30.56
16.43
ng/l
0.30
36
252
27
20
14.60
16.30
1.1
1.1
—
—
—
0
0
148
786
2.62
15.92
1.6
1.3
2.37
1.80
u/ml
0.12
53
217
29
52
6.02
15.85
1.2
1.3
—
1.16
—
0
5
129
643
2.67
15.77
4.0
3.2
0.00
0.01
estimate
1.08
62
267
288
2150
3.91
15.62
4.4
3.8
35.46
37.35
mmol/mol
5.24
280
2057
28
25
12.14
15.59
1.0
1.1
—
—
—
0
0
120
585
2.66
15.26
2.2
1.8
0.32
0.63
mg/l
10.61
80
427
19
6
33.48
14.97
1.0
1.2
—
—
—
0
0
171
995
2.51
14.90
3.8
2.8
—
—
—
0
0
30
59
5.50
14.88
1.3
1.1
—
—
—
0
0
111
532
2.65
14.49
1.4
1.3
418.08
23.87
iu/ml
0.48
25
172
22
36
6.48
13.10
1.1
2.1
2.65
2.61
g/l
0.08
22
36
51
167
3.43
13.06
2.2
2.8
0.25
0.24
g/l
0.65
46
162
317
2739
6.70
12.84
17.8
9.4
14.50
18.82
mg/l
2.02
258
2046
106
523
2.52
12.80
1.4
1.3
1.35
10.81
u/ml
2.05
42
221
22
37
6.30
12.76
1.1
2.1
6.46
6.94
g/l
0.90
22
37
22
37
6.30
12.76
1.1
2.1
—
—
—
0
0
22
37
6.30
12.76
1.1
2.1
3.31
3.45
g/l
0.30
22
37
72
297
2.83
12.40
2.0
3.2
878.35
455.85
ng/l
0.30
51
239
18
10
18.97
12.19
1.7
1.0
123.21
172.50
mmol/24h
—
18
10
127
693
2.36
12.18
4.7
6.1
1.02
1.06
inr
1.14
45
243
107
553
2.39
11.50
3.4
2.8
1.02
1.02
kg/l
0.74
15
63
72
310
2.70
11.36
3.3
2.7
41.90
257.01
ng/l
2.06
21
159
42
134
3.45
11.15
2.7
2.8
1.22
1.22
mmol/l
0.28
42
111
20
21
10.07
10.41
1.5
1.6
—
—
—
0
0
293
2383
3.27
10.30
4.0
3.1
5.48
5.57
mmol/l
0.76
283
2252
21
25
8.90
10.21
1.3
1.2
—
—
—
0
0
297
2440
3.44
10.14
12.9
7.5
97.02
95.81
ml/min/173m2
0.55
264
1956
13
8
16.85
8.62
1.2
1.4
—
—
—
0
0
65
306
2.40
8.36
1.6
1.4
23.12
22.83
iu/l
0.02
57
263
12
7
17.74
8.13
1.1
1.4
67.23
67.57
nmol/24h
—
12
7
15
15
10.42
8.11
1.8
2.0
2.37
1.88
nmol/l
0.26
15
15
67
326
2.33
7.98
2.4
2.2
0.58
0.89
e6/l
0.79
34
182
15
16
9.77
7.86
1.2
1.0
0.94
1.03
u/l
—
7
9
35
124
3.04
7.81
2.6
4.2
66.03
72.32
ng/l
0.26
30
116
17
23
7.73
7.78
1.1
1.3
—
—
—
0
0
12
8
15.51
7.77
1.1
1.0
—
—
—
0
0
24
69
3.68
7.42
3.4
7.1
23.14
24.08
mmol/l
0.59
24
69
294
2508
2.75
7.30
18.7
11.5
13.80
13.95
%
0.23
288
2474
35
130
2.90
7.19
4.1
5.4
2.18
1.91
mmol/l
0.22
29
101
10
5
20.56
7.17
1.2
1.0
—
—
—
0
0
10
5
20.56
7.17
1.2
1.2
—
—
—
0
0
21
57
3.87
7.03
1.3
1.4
391.40
343.19
ug/g
—
10
33
37
144
2.77
6.98
1.3
1.3
11.30
10.88
u/l
0.05
30
116
17
28
6.34
6.87
1.0
2.2
39.86
40.20
g/l
0.09
17
28
42
180
2.53
6.56
1.8
1.5
—
—
—
0
0
16
27
6.17
6.39
2.6
4.9
155.46
59.89
u/ml
—
5
9
55
270
2.25
6.35
1.8
1.6
—
—
—
0
0
246
2002
1.93
6.11
3.4
2.8
29.97
33.05
u/l
0.49
239
1929
17
33
5.38
6.10
1.0
2.2
9.38
10.18
g/l
0.47
17
33
15
25
6.23
6.07
1.1
1.2
—
—
—
0
0
15
25
6.23
6.07
1.1
1.2
—
—
—
0
0
38
163
2.51
5.92
2.0
1.8
3.46
3.00
mg/l
0.20
27
109
15
26
5.99
5.91
1.1
1.2
—
—
—
0
0
15
26
5.99
5.91
1.1
1.2
—
—
—
0
0
15
26
5.99
5.91
1.1
1.2
—
—
—
0
0
40
179
2.41
5.70
1.8
1.4
—
—
—
0
0
29
113
2.72
5.47
1.3
1.7
—
—
—
0
0
8
5
16.34
5.43
1.1
1.6
—
—
—
0
0
8
5
16.34
5.43
1.1
1.4
—
—
—
0
0
8
5
16.34
5.43
1.0
1.2
—
—
—
0
0
24
86
2.93
5.27
1.3
1.0
0.77
1.36
u/ml
0.36
13
42
82
498
1.86
5.25
1.7
2.1
9256.58
2424.97
umol/l
0.52
73
465
10
12
8.55
5.09
1.1
1.0
—
—
%
—
0
0
9
9
10.24
5.05
1.6
1.7
26.33
26.22
umol/l
—
9
9
38
176
2.31
5.02
6.9
7.4
103.87
104.74
mmol/l
0.63
38
176
44
220
2.16
4.84
3.0
2.4
30.26
32.79
u/l
0.22
39
183
14
30
4.83
4.74
1.1
1.2
—
—
—
0
0
23
87
2.77
4.59
1.2
1.5
0.03
0.05
iu/ml
—
9
17
13
27
4.97
4.55
1.4
2.0
18.87
17.08
%
—
7
14
8
8
10.21
4.54
1.0
1.0
—
—
—
0
0
15
45
3.45
4.38
1.1
1.3
—
—
—
0
0
126
913
1.62
4.15
2.1
1.7
—
—
—
0
0
71
444
1.77
4.06
1.7
1.8
1.37
1.31
%
0.47
66
416
24
101
2.49
3.92
1.7
1.4
—
—
—
0
0
11
23
4.91
3.90
1.2
1.1
161.23
182.20
iu/ml
0.12
11
23
87
586
1.66
3.78
1.5
1.6
1.39
1.39
mmol/l
0.01
74
521
21
85
2.57
3.71
1.2
1.2
—
—
—
0
0
14
46
3.14
3.57
1.4
4.2
9.39
8.79
kpa
0.69
14
46
9
17
5.41
3.53
1.2
1.5
—
—
—
0
0
8
13
6.28
3.52
1.5
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
13
6.28
3.52
1.4
1.2
—
—
—
0
0
23
100
2.40
3.52
2.0
3.5
2.06
1.02
mmol/l
0.68
17
73
23
102
2.35
3.38
1.3
1.1
0.19
2.97
u/ml
2.68
11
57
16
59
2.80
3.37
1.7
4.8
59.38
56.51
%
0.36
16
59
19
77
2.56
3.36
1.7
2.3
232.21
71.88
ng/l
0.46
14
69
15
54
2.86
3.30
1.2
1.1
—
—
—
0
0
20
84
2.47
3.30
1.2
1.2
—
—
—
0
0
17
66
2.66
3.27
1.0
1.0
3.43
1.98
u/ml
—
6
34
22
100
2.29
3.07
1.5
2.2
2.46
6.17
iu/l
—
7
39
12
36
3.42
3.05
1.3
1.2
—
—
—
0
0
17
69
2.54
3.01
5.1
4.9
0.58
0.67
%
0.75
17
69
108
803
1.52
3.00
2.1
2.1
—
—
—
0
0
48
292
1.76
3.00
2.2
2.1
1541.32
2786.40
u/l
0.59
15
119
8
17
4.80
2.93
1.0
1.1
2810.75
1636.35
miu/ml
—
8
17
11
32
3.52
2.92
1.0
1.1
—
—
—
0
0
15
58
2.66
2.91
1.5
4.4
4.06
4.05
e9/l
0.00
15
58
28
144
2.03
2.90
8.9
11.7
1.98
1.23
mmol/l
0.58
19
117
59
384
1.66
2.89
1.7
1.8
—
—
—
0
0
46
280
1.75
2.87
1.9
2.6
4.11
6.04
umol/l
1.07
37
237
8
18
4.53
2.81
1.1
1.0
49.16
28.81
u/ml
—
8
18
5
6
8.44
2.76
1.0
1.3
—
—
—
0
0
8
19
4.29
2.69
1.8
1.6
—
—
—
0
0
36
209
1.81
2.63
6.5
4.1
—
—
—
0
0
5
7
7.23
2.55
1.2
1.3
—
—
—
0
0
16
69
2.39
2.52
1.6
1.6
—
—
—
0
0
278
2546
1.62
2.50
4.0
3.4
2.98
2.91
mmol/l
0.70
267
2433
8
21
3.88
2.48
1.3
1.6
5.02
5.43
mmol/l
—
8
21
96
726
1.46
2.39
2.1
2.0
—
—
—
0
0
12
46
2.67
2.38
1.5
1.3
—
—
—
0
0
12
46
2.67
2.38
1.5
1.3
—
—
—
0
0
37
224
1.74
2.37
2.5
1.6
—
—
—
0
0
13
280
0.44
2.27
1.2
1.5
—
—
—
0
0
68
485
1.51
2.25
1.7
1.9
—
—
—
0
0
27
152
1.85
2.20
2.5
2.0
80.36
83.42
ml/min/173m2
0.14
14
60
101
785
1.42
2.14
1.8
1.5
—
—
—
0
0
14
62
2.31
2.10
5.7
3.5
50.00
52.95
%
0.17
14
62
5
10
5.06
2.08
3.8
3.1
—
—
—
0
0
5
10
5.06
2.08
1.2
1.0
—
—
—
0
0
10
38
2.68
2.02
1.1
1.4
—
—
—
0
0
11
240
0.44
2.00
1.2
1.4
—
—
—
0
0
11
240
0.44
2.00
1.2
1.4
—
—
—
0
0
11
239
0.44
1.98
1.2
1.4
—
—
—
0
0
11
239
0.44
1.98
1.2
1.4
—
—
—
0
0
8
27
3.01
1.95
1.8
1.4
—
—
—
0
0
9
33
2.78
1.94
1.0
1.3
—
—
—
0
0
273
2531
1.48
1.87
3.9
3.2
4.81
4.81
mmol/l
0.02
263
2427
7
23
3.09
1.81
1.1
1.0
—
—
—
0
0
8
29
2.80
1.80
1.5
2.2
—
—
—
0
0
6
18
3.38
1.75
1.2
1.8
—
—
—
0
0
6
18
3.38
1.75
1.7
1.8
—
—
—
0
0
8
30
2.71
1.73
1.1
1.3
—
—
—
0
0
5
13
3.89
1.72
1.4
1.5
—
—
—
0
0
271
2521
1.44
1.71
3.8
3.2
1.46
1.50
mmol/l
0.81
260
2414
12
55
2.23
1.69
1.3
1.2
3.20
4.91
u/ml
—
5
22
14
257
0.52
1.59
1.2
1.5
—
—
—
0
0
5
15
3.37
1.53
1.4
1.1
98.18
180.79
pmol/l
—
5
15
5
15
3.37
1.53
1.4
1.5
—
—
—
0
0
31
203
1.58
1.52
1.1
1.0
—
—
—
0
0
6
21
2.89
1.51
1.5
1.3
10.44
10.02
u/l
—
6
21
7
28
2.53
1.46
1.3
1.3
—
—
—
0
0
26
166
1.62
1.42
3.3
2.5
—
—
—
0
0
26
166
1.62
1.42
1.5
1.6
—
—
—
0
0
7
29
2.44
1.40
1.1
1.3
—
—
—
0
0
7
29
2.44
1.40
1.3
1.3
—
—
—
0
0
7
29
2.44
1.40
1.1
1.3
—
—
—
0
0
7
29
2.44
1.40
1.1
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
17
2.97
1.36
1.0
1.0
117.00
139.24
%
—
5
17
5
18
2.80
1.29
1.0
1.1
—
—
—
0
0
6
26
2.33
1.19
1.0
1.6
—
—
—
0
0
6
26
2.33
1.19
1.0
1.6
—
—
—
0
0
7
30
2.36
1.13
1.1
1.3
—
—
—
0
0
7
30
2.36
1.13
1.1
1.3
—
—
—
0
0
8
41
1.97
1.09
1.0
1.5
—
—
—
0
0
7
32
2.21
1.08
1.4
1.1
29.21
35.70
nmol/l
—
7
23
10
52
1.95
1.07
1.2
1.6
7.08
7.43
mmol/l
—
10
45
9
47
1.94
1.03
1.1
2.0
—
—
—
0
0
12
68
1.79
1.02
2.1
1.6
—
—
—
0
0
9
49
1.86
0.99
1.2
1.6
—
—
—
0
0
32
429
0.72
0.99
1.3
1.5
—
—
—
0
0
5
23
2.19
0.98
1.8
1.3
—
—
—
0
0
10
54
1.88
0.97
1.0
1.1
—
—
—
0
0
0
32
0.00
0.95
0.0
2.0
—
263.60
—
0
16
256
2424
1.26
0.95
3.5
3.0
1.23
1.22
mmol/l
0.12
245
2312
25
176
1.46
0.94
2.2
1.9
24.04
34.91
u/ml
0.46
25
168
6
28
2.16
0.92
1.5
1.6
—
—
—
0
0
6
30
2.02
0.87
1.2
1.9
942.33
766.40
e6/l
—
6
30
8
45
1.80
0.85
2.1
2.3
144.50
132.55
g/l
—
8
33
18
124
1.48
0.77
1.2
1.3
—
—
—
0
0
5
25
2.02
0.73
2.2
1.5
59.60
70.36
umol/l
—
5
25
7
41
1.72
0.70
1.0
1.4
—
—
—
0
0
28
215
1.33
0.68
1.3
1.4
—
—
—
0
0
51
425
1.24
0.67
3.0
3.8
28.72
11.96
mg/mmol
0.35
32
280
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
14
100
1.42
0.52
1.3
1.6
—
—
—
0
0
6
40
1.51
0.52
2.3
2.5
—
—
—
0
0
259
2503
1.17
0.51
5.0
3.9
—
—
—
0
0
62
544
1.17
0.49
1.9
2.1
—
—
—
0
0
5
82
0.60
0.46
1.2
1.3
—
—
—
0
0
7
50
1.41
0.45
4.1
2.9
6.14
74.36
u/ml
—
7
44
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
5
36
1.39
0.38
1.4
1.5
—
—
—
0
0
9
68
1.33
0.38
1.8
1.9
—
—
—
0
0
19
153
1.26
0.36
1.2
1.5
—
—
—
0
0
18
144
1.26
0.36
2.2
2.6
23.80
21.82
%
—
6
36
6
45
1.34
0.34
3.0
1.4
1.93
1.19
ug/l
—
6
40
10
75
1.34
0.30
2.0
2.0
—
—
—
0
0
13
102
1.29
0.30
2.5
1.9
0.60
0.59
ug/l
—
7
38
126
1202
1.08
0.25
2.3
2.5
—
—
—
0
0
5
40
1.25
0.22
1.8
1.5
6.54
7.23
mmol/l
—
5
40
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
11.7
—
38.14
—
0
7
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
18
207
0.86
0.19
1.3
1.5
—
—
—
0
0
15
175
0.85
0.19
1.6
1.4
—
—
—
0
0
36
388
0.92
0.15
1.9
1.5
—
—
—
0
0
17
154
1.11
0.10
2.4
2.0
—
—
—
0
0
20
187
1.07
0.06
1.2
1.3
275.88
263.31
miu/ml
—
8
97
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.92
-0.00
1.6
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
17
170
1.00
-0.00
1.5
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
6.12
—
0
5
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_POSTVIRFAT and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have G6_POSTVIRFAT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: G6_POSTVIRFAT – Postviral fatigue syndrome
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data